Skip to main content

White paper

New dimensions in life sciences research

Proving the impact on clinical outcomes as well as costs.

Using integrated data to create a dimensional view of outcomes and cost

Integrating data at scale is growing easier with advances in de-identification software, development of certified data models to protect privacy, and cloud-based computing. The resulting value is a dimensional view of outcomes and cost. Traditional analysis leaves vital information out of the value equation.

Improve decisions, enrich research and strengthen strategies

Life sciences research is benefiting from the powerful addition of integrated data. Researchers can now gain data in sufficient amounts to power robust analytics. This white paper explores how this new data can improve early business decisions, enrich research activity and strengthen market strategies.

Related healthcare insights

View all

Article

4 ways small biopharma can harness RWD

Small and emerging biopharma companies are already having an impact on the industry. Learn how RWD can enhance the ability to innovate.

Article

Reassessing the Inflation Reduction Act with real-world evidence

Cut through the noise of the Inflation Reduction Act of 2022 with key points aimed to help life sciences leaders leverage impactful data.

Article

Catalyze the use of RWE in life sciences

Discover how using real-world evidence (RWE) in the life sciences industry can help catapult learning and drive impact for your company.